Natera (NTRA) Net Margin (2014 - 2026)
Natera's (NTRA) quarterly Net Margin came in at 8.89% in Q2 2026, up 958.0% on a YoY basis from 0.84% in Q2 2025, and up 27.22% quarter-over-quarter from 12.22% in Q1 2026.
Powered by 
Analysis
Natera (NTRA) Net Margin (2014 - 2026) Analysis & Trends
Natera (NTRA) has reported Net Margin for 13 consecutive years, with 8.89% the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Net Margin rose 958.0% year-over-year to 8.89%; the trailing twelve-month figure through Jun 2026 stood at 7.1% (up 373.0% YoY), and the FY2025 full-year result was 9.03%, down 19.0% from the prior year.
- Net Margin grew to 8.89% in Q2 2026 per NTRA's latest filing, from 12.22% in the prior quarter.
- Across five years, Net Margin topped out at 7.11% in Q4 2025 and bottomed at 73.23% in Q2 2022.
- Historically, Net Margin has averaged 27.85% across 5 years, with a median of 16.58% in 2025.
- The sharpest annual moves came in 2022 and 2023: Net Margin plunged 2947 bps in 2022, then soared 6996 bps in 2023.
- Over 5 years, Net Margin stood at 65.63% in 2022, then jumped by 107 bps to 4.34% in 2023, then slumped by 164 bps to 2.77% in 2024, then soared by 357 bps to 7.11% in 2025, then sank by 225 bps to 8.89% in 2026.
- According to Business Quant data, Net Margin over the past three periods registered 8.89%, 12.22%, and 7.11% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Natera | 49.39 Bn | 48.29 Bn | 486.15 Mn | -8.89% |
| 2 | Quest Diagnostics | 27.49 Bn | 26.86 Bn | 1.03 Bn | 10.65% |
| 3 | Labcorp Holdings | 26.51 Bn | 26.37 Bn | 1.11 Bn | 8.02% |
| 4 | Guardant Health | 23.17 Bn | 22.12 Bn | 219.03 Mn | -35.87% |
| 5 | Tempus AI | 12.59 Bn | 11.77 Bn | 274.25 Mn | 2.22% |
| 6 | Caris Life Sciences | 8.01 Bn | 7.22 Bn | 182.38 Mn | -0.24% |
| 7 | Sotera Health | 5.53 Bn | 5.17 Bn | 177.96 Mn | 16.69% |
| 8 | BillionToOne | 4.80 Bn | 4.25 Bn | 77.11 Mn | 7.36% |
| 9 | Adaptive Biotechnologies | 4.40 Bn | 4.05 Bn | 51.39 Mn | -22.65% |
| 10 | iRhythm Holdings | 3.68 Bn | 3.08 Bn | 163.21 Mn | -0.17% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -8.89% |
| Mar 31, 2026 | -12.22% |
| Dec 31, 2025 | 7.11% |
| Sep 30, 2025 | -14.78% |
| Jun 30, 2025 | -18.47% |
| Mar 31, 2025 | -13.34% |
| Dec 31, 2024 | -2.77% |
| Sep 30, 2024 | -7.18% |
| Jun 30, 2024 | -9.07% |
| Mar 31, 2024 | -18.38% |
| Dec 31, 2023 | 4.34% |
| Sep 30, 2023 | -40.64% |
| Jun 30, 2023 | -42.39% |
| Mar 31, 2023 | -56.64% |
| Dec 31, 2022 | -65.63% |
| Sep 30, 2022 | -57.67% |
| Jun 30, 2022 | -73.23% |
| Mar 31, 2022 | -71.39% |
| Dec 31, 2021 | -81.24% |
| Sep 30, 2021 | -95.67% |